BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 6749509)

  • 1. Clinical pharmacokinetics of atenolol--a review.
    Kirch W; Görg KG
    Eur J Drug Metab Pharmacokinet; 1982; 7(2):81-91. PubMed ID: 6749509
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Single intravenous dose kinetics accumulation of atenolol in patients with impaired renal function and on hemodialysis.
    Kirch W; Schäfer M; Braun M
    Arch Toxicol Suppl; 1980; 4():366-9. PubMed ID: 6933939
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of atenolol in relation to renal function.
    Kirch W; Köhler H; Mutschler E; Schäfer M
    Eur J Clin Pharmacol; 1981 Jan; 19(1):65-71. PubMed ID: 7461026
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics, pharmacology of atenolol and effect of renal disease.
    Wan SH; Koda RT; Maronde RF
    Br J Clin Pharmacol; 1979 Jun; 7(6):569-74. PubMed ID: 465278
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical pharmacokinetics of beta-adrenoreceptor blocking drugs.
    Johnsson G; Regàrdh CG
    Clin Pharmacokinet; 1976; 1(4):233-63. PubMed ID: 13958
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical experience with atenolol in patients with chronic liver disease.
    Kirch W; Schäfer-Korting M; Mutschler E; Ohnhaus EE; Braun W
    J Clin Pharmacol; 1983 Apr; 23(4):171-7. PubMed ID: 6863581
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of pretreatment with cimetidine on the bioavailability and disposition of atenolol and metoprolol.
    Houtzagers JJ; Streurman O; Regårdh CG
    Br J Clin Pharmacol; 1982 Jul; 14(1):67-72. PubMed ID: 6125199
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of atenolol in patients with terminal renal failure and influence of haemodialysis.
    Flouvat B; Decourt S; Aubert P; Potaux L; Domart M; Goupil A; Baglin A
    Br J Clin Pharmacol; 1980 Apr; 9(4):379-85. PubMed ID: 7378254
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical pharmacologic observations on atenolol, a beta-adrenoceptor blocker.
    Brown HC; Carruthers SG; Johnston GD; Kelly JG; McAinsh J; McDevitt DG; Shanks RG
    Clin Pharmacol Ther; 1976 Nov; 20(5):524-34. PubMed ID: 10125
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kinetics and absolute bioavailability of atenolol.
    Mason WD; Winer N; Kochak G; Cohen I; Bell R
    Clin Pharmacol Ther; 1979 Apr; 25(4):408-15. PubMed ID: 428185
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Studies on the pharmacokinetics and pharmacodynamics of atenolol in man.
    Fitzgerald JD; Ruffin R; Smedstad KG; Roberts R; McAinsh J
    Eur J Clin Pharmacol; 1978 May; 13(2):81-9. PubMed ID: 658112
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Food-induced reduction in bioavailability of atenolol.
    Melander A; Stenberg P; Liedholm H; Scherstén B; Wåhlin-Boll E
    Eur J Clin Pharmacol; 1979 Nov; 16(5):327-30. PubMed ID: 520399
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of atenolol in patients with renal impairment.
    Sassard J; Pozet N; McAinsh J; Legheand J; Zech P
    Eur J Clin Pharmacol; 1977 Nov; 12(3):175-80. PubMed ID: 590303
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interaction of metoprolol, propranolol and atenolol with concurrent administration of cimetidine.
    Kirch W; Spahn H; Köhler H; Ohnhaus EE; Mutschler E
    Klin Wochenschr; 1982 Nov; 60(22):1401-7. PubMed ID: 7176462
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Atenolol kinetics in renal failure.
    McAinsh J; Holmes BF; Smith S; Hood D; Warren D
    Clin Pharmacol Ther; 1980 Sep; 28(3):302-9. PubMed ID: 7408390
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of inflammatory disease on the clinical pharmacokinetics of atenolol and metoprolol.
    Kirch W; Spahn H; Ohnhaus EE; Köhler H; Heinz U; Mutschler E
    Biopharm Drug Dispos; 1983; 4(1):73-81. PubMed ID: 6839004
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Atenolol disposition in young and elderly subjects.
    Rubin PC; Scott PJ; McLean K; Pearson A; Ross D; Reid JL
    Br J Clin Pharmacol; 1982 Feb; 13(2):235-7. PubMed ID: 7059422
    [No Abstract]   [Full Text] [Related]  

  • 18. Metabolism of atenolol in man.
    Reeves PR; McAinsh J; McIntosh DA; Winrow MJ
    Xenobiotica; 1978 May; 8(5):313-20. PubMed ID: 27019
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Balanced pharmacokinetics and metabolism of bisoprolol.
    Leopold G
    J Cardiovasc Pharmacol; 1986; 8 Suppl 11():S16-20. PubMed ID: 2439789
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interaction of atenolol with furosemide and calcium and aluminum salts.
    Kirch W; Schäfer-Korting M; Axthelm T; Köhler H; Mutschler E
    Clin Pharmacol Ther; 1981 Oct; 30(4):429-35. PubMed ID: 7285476
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.